Trident Lifeline Limited (BOM:543616)

India · Delayed Price · Currency is INR

413.75

-8.75 (-2.07%)

At close: Nov 6, 2026

Market Cap	4.94B +42.0%
Revenue (ttm)	1.60B +44.2%
Net Income	234.07M +62.9%
EPS	19.66 +58.6%
Shares Out	11.93M
PE Ratio	21.04
Forward PE	n/a
Dividend	1.00 (0.24%)
Ex-Dividend Date	Oct 30, 2026

Volume	4,800
Open	423.95
Previous Close	422.50
Day's Range	412.00 - 423.95
52-Week Range	229.95 - 442.00
Beta	-0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 26, 2026

About Trident Lifeline

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. It provides various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. The company is also involv... [Read more]

Industry Pharmaceutical Preparations

Founded 2014

Employees 46

Stock Exchange Bombay Stock Exchange

Ticker Symbol 543616

Full Company Profile

Financial Performance

In fiscal year 2026, Trident Lifeline's revenue was 1.29 billion, an increase of 48.36% compared to the previous year's 869.65 million. Earnings were 190.41 million, an increase of 62.08%.

Financial Statements